Sharon Mates sold $8.7M of Intra-Cellular Therapies (ITCI)

Executed Dec 4 2024, disclosed Dec 6 2024, 2 days later.

Value, as filed

$8.7M

102,697 sh across 4 lots

Executed

Dec 4 2024

the trade date, as filed

Disclosed

Dec 6 2024

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

SM Sharon Mates Chairman and CEO profile →

Sharon Mates (Chairman and CEO) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in ITCI. The largest single filing was $8.7M of ITCI (102,697 sh across 4 lots, as filed), executed Dec 4 2024.

The name

ITCI ITCI ITCI · 7 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→